Latest Breaking News On - Phase 3 checkmate 274 trial - Page 1 : vimarsana.com

Nivolumab following radical surgery continued to display a benefit in disease-free survival in patients with muscle-invasive urothelial carcinoma and muscle-invasive bladder cancer.

United statesMatthew milowskyNivolumab opdivoLineberger comprehensive cancer centerUrologic oncology programAmerican urological association annual meetingUrological association annualComprehensive cancer centerAmerican urological association annual meetingMuscle invasive urothelial carcinomaMuscle invasive bladder cancerPhase 3 checkmate 274 trial